AT
IART icon

American Trust’s Integra LifeSciences IART Stock Holding History

American Trust’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,341
Closed -$261K – 344
2023
Q2 		$261K Sell
6,341
-320
-5% -$15.4K 0.02% 333
2023
Q1 		$382K Sell
6,661
-156
-2% -$8.79K 0.03% 260
2022
Q4 		$382K Buy
6,817
+1,942
+40% +$98.8K 0.04% 267
2022
Q3 		$207K Sell
4,875
-189
-4% -$9.68K 0.02% 385
2022
Q2 		$274K Buy
5,064
+196
+4% +$11.8K 0.02% 329
2022
Q1 		$313K Buy
+4,868
New +$321K 0.02% 342

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Trust's IART Position: Q3 2023 in Review

American Trust sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 6,341 shares — an estimated $261K sold.

American Trust first reported a position in IART in Q1 2022 and held it in 6 quarters. The position peaked at $382K in Q1 2023. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • American Trust reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • American Trust sold 6,341 Integra LifeSciences shares in Q3 2023, an estimated $261K.
  • American Trust first reported a position in Integra LifeSciences in Q1 2022 and held it in 6 quarters.
  • American Trust's Integra LifeSciences position peaked at $382K in Q1 2023.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on American Trust's 13F filing for Q3 2023, filed 15 Nov 2023.